Matinas Bio Pharma Holdings announced it raised $1.65 Million in an initial filing from an offering of $3.3 Million
Matinas Bio Pharma Holdings announced it raised $1.65 Million in an initial filing from an offering of $3.3 Million
02/19/25, 9:08 PM
Location
bedminsterMoney raised
$1.65 million
Industry
biotechnology
Round Type
seed
Company Info
Location
1545 route 206 south
bedminster, new jersey, united states
Additional Info
Matinas BioPharma (NYSE AMER: MTNB) is a biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology. The Company is developing its own internal portfolio of products as well as partnering with leading pharmaceutical companies to develop novel formulations that capitalize on the unique characteristics of the LNC platform.